MYC and cancer: Furthermore, GEPIA2 and TCGA database analyses showed elevated c-Myc, PD-L1, and TP53 expression across multiple cancer types, with leukemia patients exhibiting high gene expression displaying reduced 5-year survival rates (Fig 1E~H).